Corey Goodman, a partner with venBio in San Francisco, is a renowned neuroscientist, entrepreneur, CEO, and corporate executive. Until May 2009, he was President of Pfizer's Biotherapeutics and Bioinnovation Center, a new division focused on biologics and new models to harness external innovation and drug discovery, and a member of Pfizer's Executive Leadership Team. Dr. Goodman was co-founder of Exelixis and Renovis, and CEO of Renovis until its acquisition by Evotec. He is a former professor at Stanford University and UC Berkeley, co-founder of Berkeley's Wills Neuroscience Institute, and currently an Adjunct Professor at UC San Francisco. Dr. Goodman is an elected member of the U.S. National Academy of Sciences, the American Academy of Arts and Sciences, and the American Philosophical Society. His honors include, amongst others, the Alan T. Waterman Award, the Canada Gairdner Award, and the March of Dimes Prize. He is a member of California Council on Science and Technology, and advises several university innovation centers and disease foundations. He is Chair of the Board of several companies, including Limerick BioPharma, Oligasis, and Second Genome, and a member of the Board of several others, including NeuroTherapeutics and Mirna. Dr. Goodman is located in venBio's San Francisco office.